Log on / register
Feedback | Support | My details
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
Mackenzie CD, Geary TG, Gerlach JA
Filaria J 2003, 2 Suppl 1:S5
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
38%38%


 Editorial
Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas.
Duke BOL
Filaria Journal 2003, 2(Suppl 1):S1 (24 October 2003)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.